Adaptive resistance publications

  1. Vipparthi K, Hari K, Chakraborty P, Ghosh S, Patel AK, Ghosh A, Biswas NK, Sharan R, Arun P, Jolly MK, Singh S (2022). Spontaneous differentiation leads to emergence of hybrid cell states related to poor prognosis in oral cancer. iScience, 25(5): 104317 
  1. Pillai M*, Chen Z*, Jolly MK#, Li C# (2022). Quantitative landscapes reveal trajectories of cell-state transitions associated with drug resistance in melanoma. iScience, in press (bioRxiv: 488373) 
  1. Sahoo S, Mishra A, Kaur H, Hari K, Muralidharan S, Mandal S, Jolly MK# (2021). A mechanistic model captures the emergence and implications of non-genetic heterogeneity and reversible drug resistance in ER+ breast cancer cells. NAR Cancer, 3 (3): zcab027 
  1. Jain P, Duddu AS, Jolly MK# (2022). Stochastic population dynamics of cancer stemness and adaptive response to therapies. Essays in Biochemistry, 66 (4): 387-398 
  1. Mohanty A, Nam A, Pozhiktov A, Bhattacharyya S, Yang L, Nathan A, Xiewei W, Srivastava S, Mambetsariev I, Nelson M, Subbalakshmi A R, Guo L, Nasser MW, Batra SK, Orban J, Jolly MK, Maserralli E, Kulkarni P, Salgia R (2020). A non-genetic mechanism for chemoresistance in lung cancer: the role of integrin β4/paxillin axis. iScience, 23 (9): 101496